Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and ...
A securities class action against Alexion Pharmaceuticals Inc. was “related” to an SEC investigation and should have been ...
Hosted on MSN2mon
Pharmaceutical giant addresses critical health issue by rethinking its delivery trucks: 'Another milestone'vice president of global supply chain and product strategy lead at Alexion AstraZeneca Rare Disease, said, per Irish Tech News. "This is another step in the right direction as we strive to run ...
Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, has entered into a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo for the treatment of ...
Bracing for a federal funding drought and higher state costs for Medicare and Medicaid, Gov. Ned Lamont urged pharma ...
Lauren Drouin is the director of analytical development and the Genomic Medicine Unit at Alexion AstraZeneca Rare Disease. As a dynamic scientist with unique expertise in current research and industry ...
Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, has entered into a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo for the treatment of ...
The Manila Times on MSN9d
AstraZeneca wants to do clinical trials in PH – RoqueMULTINATIONAL pharmaceutical firm AstraZeneca (AZ) wants to conduct the majority of its clinical trials in the Philippines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback